Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China · Delayed Price · Currency is CNY 15.85
-0.97 (-5.77%)
Aug 27, 2026, 3:00 PM CST
SHA:605266 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 814.83 | 878.58 | 776.05 | 857.93 | 932.6 | 983.1 |
Trading Asset Securities | 56 | - | 50 | 50 | 3 | - |
Cash & Short-Term Investments | 870.83 | 878.58 | 826.05 | 907.93 | 935.6 | 983.1 |
Cash Growth | 4.49% | 6.36% | -9.02% | -2.96% | -4.83% | -39.38% |
Accounts Receivable | 733.69 | 1,059 | 425.75 | 440.48 | 591.65 | 227.87 |
Other Receivables | 52.25 | 50.17 | 60.68 | 56.94 | 53.54 | 56.96 |
Receivables | 785.94 | 1,110 | 486.44 | 497.42 | 645.19 | 284.83 |
Inventory | 2,075 | 2,114 | 3,128 | 2,374 | 2,166 | 1,121 |
Prepaid Expenses | - | 15.04 | 14.04 | 12.87 | - | - |
Other Current Assets | 250.23 | 216.83 | 228.09 | 145.79 | 192.89 | 107.8 |
Total Current Assets | 3,982 | 4,334 | 4,683 | 3,938 | 3,939 | 2,497 |
Property, Plant & Equipment | 2,186 | 2,283 | 2,597 | 2,687 | 2,644 | 1,901 |
Long-Term Investments | 19.67 | 22.61 | 30.54 | 47.42 | 18.34 | 9.8 |
Goodwill | 2,421 | 2,421 | 2,456 | 2,403 | 2,243 | 415.3 |
Other Intangible Assets | 75.18 | 82.01 | 85.36 | 92.2 | 90.46 | 44.75 |
Long-Term Deferred Tax Assets | 241.45 | 234.67 | 280.17 | 285.43 | 287.22 | 14.64 |
Long-Term Deferred Charges | 313.28 | 367.37 | 485.3 | 485.93 | 415.89 | 331.86 |
Other Long-Term Assets | 11.87 | 8.94 | 6.05 | 10.61 | 6.18 | - |
Total Assets | 9,251 | 9,754 | 10,623 | 9,949 | 9,644 | 5,214 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2,114 | 2,217 | 2,783 | 2,639 | 2,756 | 1,695 |
Accrued Expenses | 126.65 | 202.29 | 184.59 | 216.07 | 281.91 | 105.3 |
Short-Term Debt | 1,984 | 1,996 | 1,604 | 749.61 | 201.48 | 30 |
Current Portion of Long-Term Debt | 836.99 | 283.55 | 249.74 | 572.5 | 155.19 | 5.41 |
Current Portion of Leases | - | 522.42 | 389.42 | 423.84 | 422.6 | 378.41 |
Current Income Taxes Payable | 40.77 | 30.08 | 19.77 | 44.93 | 66.87 | 42.42 |
Current Unearned Revenue | 26.58 | 26.16 | 25.23 | 28.49 | 37.43 | 18.07 |
Other Current Liabilities | 83.47 | 103.45 | 212.14 | 185.57 | 304.14 | 146.67 |
Total Current Liabilities | 5,212 | 5,381 | 5,467 | 4,860 | 4,225 | 2,421 |
Long-Term Debt | 815.28 | 967.82 | 1,190 | 1,022 | 1,192 | 25.23 |
Long-Term Leases | 472.75 | 509.13 | 909.27 | 927.52 | 963.28 | 842.93 |
Long-Term Unearned Revenue | 10.84 | 11.06 | 11.53 | 11.96 | 12.63 | 13.06 |
Long-Term Deferred Tax Liabilities | 204.01 | 213.28 | 265.03 | 282.25 | 275.44 | 19.03 |
Other Long-Term Liabilities | - | - | - | - | 407.82 | - |
Total Liabilities | 6,715 | 7,082 | 7,843 | 7,104 | 7,076 | 3,321 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 154.54 | 154.54 | 156.66 | 128.85 | 99.16 | 69.53 |
Additional Paid-In Capital | 1,338 | 1,338 | 1,397 | 1,361 | 1,391 | 1,009 |
Retained Earnings | 1,192 | 1,326 | 1,341 | 1,379 | 1,109 | 856.89 |
Treasury Stock | -145.44 | -145.44 | -97.81 | -7.15 | -14.78 | -25.75 |
Comprehensive Income & Other | -0.9 | -0.24 | 0.12 | - | - | - |
Total Common Equity | 2,538 | 2,673 | 2,797 | 2,861 | 2,585 | 1,910 |
Minority Interest | -1.33 | -1.31 | -16.68 | -16.51 | -16.59 | -16.72 |
Shareholders' Equity | 2,536 | 2,672 | 2,781 | 2,845 | 2,568 | 1,893 |
Total Liabilities & Equity | 9,251 | 9,754 | 10,623 | 9,949 | 9,644 | 5,214 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,109 | 4,279 | 4,342 | 3,696 | 2,935 | 1,282 |
Net Cash (Debt) | -3,238 | -3,400 | -3,516 | -2,788 | -1,999 | -298.88 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -21.91 | -22.95 | -22.78 | -18.03 | -13.17 | -2.14 |
Filing Date Shares Outstanding | 156.8 | 148.16 | 154.49 | 154.62 | 154.69 | 141 |
Total Common Shares Outstanding | 156.8 | 148.16 | 154.49 | 154.62 | 154.69 | 141 |
Working Capital | -1,230 | -1,047 | -784.78 | -922.54 | -285.78 | 76 |
Book Value Per Share | 16.18 | 18.04 | 18.11 | 18.50 | 16.71 | 13.54 |
Tangible Book Value | 41.14 | 169.48 | 255.83 | 365.8 | 251.51 | 1,450 |
Tangible Book Value Per Share | 0.26 | 1.14 | 1.66 | 2.37 | 1.63 | 10.28 |
Buildings | - | 951.79 | 906.25 | 902.64 | 891.8 | 369.39 |
Machinery | - | 336.56 | 312.13 | 277.99 | 225.09 | 158.25 |
Construction In Progress | - | 194.17 | 253.85 | 202.01 | 180.56 | 73.91 |